China Pharma Holdings (CPHI) Capital Expenditures Growth (3y) (2013 - 2025)
China Pharma Holdings (CPHI) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 75.58% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.56% |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.34% |
| Sep 30, 2025 | -86.58% |
| Jun 30, 2025 | -26.00% |
| Mar 31, 2025 | 247.41% |
| Dec 31, 2024 | 40.44% |
| Sep 30, 2024 | -26.46% |
| Dec 31, 2023 | 26.40% |
| Sep 30, 2023 | -36.17% |
| Jun 30, 2023 | -26.18% |
| Mar 31, 2023 | -29.28% |
| Dec 31, 2022 | -36.49% |
| Sep 30, 2022 | 174.57% |
| Jun 30, 2022 | 712.52% |
| Mar 31, 2022 | -73.40% |
| Dec 31, 2021 | -26.56% |
| Sep 30, 2021 | 398.89% |
| Dec 31, 2020 | -75.04% |
| Sep 30, 2020 | 155.71% |
| Jun 30, 2020 | 169.46% |
| Mar 31, 2020 | 135.50% |